Search This Blog

Thursday, August 8, 2019

Achillion Pharmaceuticals EPS in-line

Achillion Pharmaceuticals (NASDAQ:ACHN): Q2 GAAP EPS of -$0.14 in-line.
Cash, cash equivalents and marketable securities of $241.3M
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)